ArticleHeliyon2023
A study on the control path of financial research resource allocation based on Rahman model.
Article in Heliyon, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The participation of scientific research firms in transactions (research results) is a prerequisite for allocation of financial resources. Resources are allocated to projects with the greatest positive impact on social welfare. In this respect, the Rahman model is a useful method for allocating financial resources. It considers the dual productivity of a system and recommends allocating financial resources to the system with greatest absolute advantage. In this study, when the dual productivity of system 1 has an absolute advantage over that of system 2, the higher-level government will still allocate all financial resources to system 1, even if its total efficiency of research savings is lower than that of system 2. However, when the research conversion rate of system 1 is at a relative disadvantage but its total efficiency of research savings and dual productivity are both at a relative advantage, there may be a change in the government's allocation of financial resources. If the initial government decision time occurs before the jump point, system 1 will be allocated all resources until it reaches the jump point, but no resources once the jump point is crossed. Furthermore, the government will allocate all financial resources to system 1 if its dual productivity, total efficiency of research savings, and research conversion rate are at a relative advantage. Collectively, these results provide a theoretical basis and practical guidance for research specialization and resource allocation.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.